JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M200415200 on February 28, 2002

J. Biol. Chem., Vol. 277, Issue 19, 16662-16672, May 10, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/19/16662    most recent
M200415200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berggård, T.
Right arrow Articles by Linse, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berggård, T.
Right arrow Articles by Linse, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Calbindin D28k Exhibits Properties Characteristic of a Ca2+ Sensor*

Tord BerggårdDagger §, Simona MironDagger , Patrik Önnerfjord, Eva ThulinDagger , Karin S. Åkerfeldt||, Jan J. Enghild**, Mikael AkkeDagger , and Sara LinseDagger DaggerDagger

From the Dagger  Department of Biophysical Chemistry, Lund University, SE-221 00 Lund, Sweden, the || Department of Chemistry, Haverford College, Haverford, Pennsylvania 19041-1392, the ** Department of Molecular and Structural Biology, University of Aarhus, DK-8000 Aarhus C, Denmark, and  Section for Connective Tissue Biology, BMC, C12, Lund University, SE-221 84 Lund, Sweden

Received for publication, January 15, 2002, and in revised form, February 27, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Calbindin D28k is a member of the calmodulin superfamily of Ca2+-binding proteins and contains six EF-hands. The protein is generally believed to function as a Ca2+ buffer, but the studies presented in this work indicate that it may also act as a Ca2+ sensor. The results show that Mg2+ binds to the same sites as Ca2+ with an association constant of ~1.4·103 M-1 in 0.15 M KCl. The four high affinity sites in calbindin D28k bind Ca2+ in a non-sequential, parallel manner. In the presence of physiological concentrations of Mg2+, the Ca2+ affinity is reduced by a factor of 2, and the cooperativity, which otherwise is modest, increases. Based on the binding constants determined in the presence of physiological salt concentrations, we estimate that at the Ca2+ concentration in a resting cell calbindin D28k is saturated to 40-75% with Mg2+ but to less than 9% with Ca2+. In contrast, the protein is expected to be nearly fully saturated with Ca2+ at the Ca2+ level of an activated cell. A substantial conformational change is observed upon Ca2+ binding, but only minor structural changes take place upon Mg2+ binding. This suggests that calbindin D28k undergoes Ca2+-induced structural changes upon Ca2+ activation of a cell. Thus, calbindin D28k displays several properties that would be expected for a protein involved in Ca2+-induced signal transmission and hence may function not only as a Ca2+ buffer but also as a Ca2+ sensor. Digestion patterns resulting from limited proteolysis of the protein suggest that the loop of EF-hand 2, a variant site that does not bind Ca2+, becomes exposed upon Ca2+ binding.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Calbindin D28k is a Ca2+-binding protein expressed in brain as well as in kidney, bone, pancreas, and other tissues (1). In some tissues it is exceptionally abundant. For example, calbindin D28k constitutes between 0.1 and 1.5% of the total soluble protein in brain, and protein levels in auditory neurons are estimated to reach concentrations of up to 2 mM (2). Calbindin D28k contains 261 amino acid residues forming six EF-hands, which are organized in a single globular domain (Fig. 1) (3, 4). The protein is a member of the calmodulin superfamily (5). Some members of this superfamily are Ca2+ sensors that undergo Ca2+-induced conformational changes resulting in the exposure of a hydrophobic surface. The hydrophobic patch typically serves as a binding surface for target molecules, which become activated or attenuated upon complex formation (6). The targets include many membrane transport proteins and enzymes (7). In this way, intracellular Ca2+ influx triggers the regulation of cellular processes, such as muscle contraction and the phosphoinositide cascade.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1.   Amino acid sequence of human calbindin D28k. The schematic on top outlines secondary structure elements, including the helix-loop-helix motif. Potential trypsin cleavage sites are shaded.

Another class of Ca2+-binding proteins are the Ca2+ buffers or signal modulators. Parvalbumin and calbindin D9k are examples of Ca2+-buffer proteins. Unlike Ca2+ sensors, the Ca2+-buffer proteins do not expose hydrophobic surfaces upon Ca2+ binding. In fact, the exposure of hydrophobic surfaces would be unfavorable for these proteins because it may limit their stability and Ca2+ affinity. Ca2+ buffer proteins are thought to be involved in deactivation of signal transducers and/or quenching of Ca2+ signals, thus protecting the cell against toxic effects of Ca2+, such as the formation of insoluble calcium phosphates (for a review see Ref. 8). The Ca2+ affinity is generally higher for buffer proteins than for sensor proteins, and the rates of Ca2+ binding and release are lower in the buffer group. Calbindin D28k is thought to prevent sustained elevations of Ca2+ by acting as an intracellular Ca2+ buffer. There is evidence that calbindin D28k has a Ca2+-buffering function in neurons. For example, increased intracellular levels of calbindin D28k causes blunted intracellular Ca2+ elevations (9), and Ca2+ transients are increased in calbindin D28k null mutant mice (10). A number of examples where Ca2+ buffering by calbindin D28k has an effect on the electrophysiological behavior of cells have also been reported (11-13). The notion that calbindin D28k acts as a Ca2+-buffering system in the cytoplasm has led to the hypothesis that calbindin D28k may protect neurons against large fluctuations in free intracellular Ca2+ and, hence, prevent cell death (14-17). However, experiments using calbindin D28k-null mutant mice subjected to cerebral ischemia did not support a cytoprotective effect of the protein (18). Although most reports deal with the Ca2+-buffering function of calbindin D28k, several lines of evidence suggest that the protein also acts as a Ca2+ sensor. Spectroscopic investigations (19) and in vitro studies using antibodies (20) have shown that calbindin D28k undergoes a conformational shift upon Ca2+ binding. Additionally, a number of putative Ca2+-dependent interactions with target proteins or brain membrane fractions have been reported (20-23), and erythrocyte membrane Ca2+-ATPase and 3',5'-cyclic nucleotide phosphodiesterase have been shown to be stimulated in a dose-dependent, saturable manner with calbindin D28k (24). Moreover, the finding that a fraction of calbindin D28k (9-55%) (20, 25-27) is specifically associated with particulate structures in the cell indicates that the protein plays other roles in addition to its function as a mobile Ca2+ buffer.

In our previous study (28), we showed that although a conformational change occurs upon Ca2+ binding, both the Ca2+-free and Ca2+-loaded forms of calbindin D28k have exposed hydrophobic surfaces. Thus, the protein behaves neither like a classical Ca2+ sensor nor like a Ca2+ buffer. The aim of the present study was to further characterize the Ca2+-induced conformational change and to determine whether calbindin D28k is likely to respond structurally to changes in the intracellular concentration of Ca2+ in the presence of physiological levels of Mg2+ and salt.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Proteins-- Human recombinant calbindin D28k was expressed in Escherichia coli and purified to homogeneity as described (29). Bovine brain calbindin D28k was purified from brain homogenate as described (28). F123 is a fragment containing EF-hands 1-3 (residues 1-132) of human calbindin D28k, whereas F456 contains EF-hands 4-6 (residues 133-261). F123 and F456 were produced by cloning techniques and expressed in E. coli (4).

Chemicals-- CaCl2 and MgCl2 of Pro Analysi quality were from Merck; quin 2 was from Fluka Buchs, Switzerland, and 5,5'-Br2-BAPTA1 was from Molecular Probes, Eugene, OR. All chemicals were of highest grade commercially available. Buffers were made Ca2+-free by incubation with a dialysis tube filled with Chelex 100 (Bio-Rad) for 2 weeks.

Preparation of Apoprotein-- All apo solutions were made from Ca2+-depleted protein, which was produced as follows. Purified protein was dissolved in 1 ml of doubly distilled water, containing an excess of EGTA (10-20 eq) at pH 8. It was then applied to a 3.4 × 20-cm Sephadex G-25 superfine gel filtration column. To abolish EGTA binding, the protein was applied to the column after 15 ml of saturated NaCl had been allowed to penetrate the top of the column. The NaCl solution had been depleted from residual Ca2+ by dialysis against Chelex 100 resin. During the gel filtration, the protein was passed through the NaCl zone and eluted, now free from EGTA, with doubly distilled Ca2+-free water. The final product contained between 0.2 and 0.6 molar eq of Ca2+, as determined from Ca2+ titrations in the presence of the chelator quin 2 or by high resolution inductively coupled plasma mass spectrometry (analysis performed by SGAB, Luleå, Sweden). 1H NMR spectroscopy was used to verify that the apo samples were free from EGTA.

Near UV CD Spectroscopy-- Near-UV CD spectra (250-300 nm) were obtained using a Jasco J-720 spectropolarimeter at 25 °C (thermostated) and quartz cuvettes with a path length of 10 mm. A spectrum was first recorded for the apoprotein (25 µM apocalbindin D28k in 0.15 M KCl, 2 mM Tris, 0.125 mM EGTA, pH 7.3). A second spectrum was recorded after adding 10 mM MgCl2. Finally, 0.5 mM CaCl2 was added, and a spectrum for the Ca2+ form was recorded.

ANS Fluorescence-- Fluorescence spectra were obtained using a PerkinElmer Life Sciences Luminescence Spectrometer LS 50 B connected to a Julabo F25 water bath. All data were collected at 25.0 °C in a quartz cuvette (10 mm path-length). For the 8-anilino-1-naphthalenesulfonic acid (ANS) fluorescence experiments, ANS was added to a final concentration of 120 to 10 µM protein in 10 mM DTT, 0.15 M KCl, 2 mM Tris, pH 7.3, with 0, 1, or 5 mM MgCl2. Fluorescence spectra were recorded between 400 and 600 nm (bandwidth 5 nm) with excitation at 385 nm (bandwidth 3 nm) and a scan rate of 50 nm per min. Two spectra were obtained for each sample and averaged.

Determination of Macroscopic Ca2+ Binding Constants-- The affinity and cooperativity of Ca2+ binding to F123, F456, or intact calbindin D28k were determined by titration with CaCl2 in the presence of a chromophoric chelator, quin 2, as described previously (30, 31). All experiments were performed in 2 mM Tris/HCl buffer at pH 7.5, either with no added salt, with 0.15 M KCl, or with 0.15 M KCl in the presence of 2 mM MgCl2. The macroscopic Ca2+ binding constants were obtained by least squares fitting of the absorbance at 263 nm versus total Ca2+ concentration by minimizing the error square sum (e.s.s.) as shown in Equation 1,


<UP>e.s.s</UP>=<LIM><OP>∑</OP><LL>i=0</LL><UL>n</UL></LIM> (A<SUB><UP>calc</UP></SUB>−A<SUB><UP>obs</UP></SUB>)<SUP>2</SUP> (Eq. 1)
where the sum runs over the n + 1 data points in the titration. The calculated absorbance at each titration point, i, was obtained as shown in Equation 2,
A<SUB><UP>calc</UP>,i</SUB>=<FENCE>(A<SUB><UP>min</UP></SUB>−A<SUB><UP>max</UP></SUB>)<FR><NU>Y<SUB>i</SUB></NU><DE>(Y<SUB>i</SUB>+K<SUB>D</SUB>)</DE></FR>+A<SUB><UP>max</UP></SUB></FENCE> · <FR><NU>V<SUB>i</SUB></NU><DE>V<SUB>0</SUB></DE></FR> (Eq. 2)
where Vi and V0 are the total volumes at point i and before adding the first CaCl2 aliquot, respectively. Amin and Amax are the respective absorbances that the Ca2+-chelator complex, and free chelator would have at no dilution. KD is the dissociation constant of the chelator-Ca2+ complex. The free Ca2+ concentration, Yi, was solved using the Newton-Raphson method from Equation 3,
Y=C<UP>Ca</UP><SUB>i</SUB>−<FR><NU>CQ<SUB>i</SUB> · Y</NU><DE>Y+K<SUB>D</SUB></DE></FR>−<FR><NU>F · CP<SUB>i</SUB> · <LIM><OP>∑</OP><LL>k=1</LL><UL>N</UL></LIM> <FENCE>k · Y<SUP>k</SUP> · <LIM><OP>∏</OP><LL>j=1</LL><UL>k</UL></LIM> K<SUB>j</SUB></FENCE></NU><DE>1+<LIM><OP>∑</OP><LL>k=1</LL><UL>N</UL></LIM> <FENCE>Y<SUP>k</SUP> · <LIM><OP>∏</OP><LL>j=1</LL><UL>k</UL></LIM> K<SUB>j</SUB></FENCE></DE></FR> (Eq. 3)
where K1 through KN are the N macroscopic binding constants and CQi, CPi, and CCai are the total chelator, protein, and Ca2+ concentrations, respectively, at point i corrected for the dilutions due to the CaCl2 additions. The initial chelator concentration, CQ0, was determined by withdrawing an aliquot of the solution and recording the absorbance at 239.5 nm in the presence of excess Ca2+ (using epsilon  = 4.2 × 104 liter mol-1 cm-1). The initial Ca2+ concentration, CCa0, was determined by high resolution inductively coupled plasma mass spectrometry (at SGAB, Luleå, Sweden). The initial protein concentration, CP0, was determined by amino acid analysis after acid hydrolysis on a withdrawn aliquot of the protein/chelator solution that had been lyophilized in a hydrolysis tube (Biomedical Centre, Uppsala, Sweden). The adjustable parameters in the fit were Amin, Amax, and the N macroscopic binding constants. The parameter F was either fixed at 1.0 or could be used as an adjustable parameter to analyze if the assumed stoichiometry (number of macroscopic binding constants used) is correct (F will end up close to 1.0) or not (F will deviate from 1.0). For presentation, the data and fitted curves were normalized according to Equation 4,
A<SUB><UP>normalized</UP></SUB>=(A−A<SUB><UP>min</UP></SUB>)/(A<SUB><UP>max</UP></SUB>−A<SUB><UP>min</UP></SUB>) (Eq. 4)
The apparent Ca2+-binding constants in the presence of Mg2+ were derived using the same method as above but with 5,5'-Br2-BAPTA instead of quin 2. The chelator 5,5'-Br2-BAPTA has a high level of selectivity against Mg2+ (log KCa = 5.65; log KMg <1, at 0.15 M KCl). Hence, differences in titration curves obtained in the interval 0-10 mM Mg2+ are due to Mg2+ effects on the protein. The resulting binding constants are apparent Ca2+ binding constants for the protein in the presence of Mg2+. These constants result from the Ca2+ affinity, the Mg2+ affinity, and competition or coupling between the two events.

Determination of Ca2+ and Mg2+ Binding Constants by Fluorescence Spectroscopy-- Mg2+ or Ca2+ binding constants were determined by monitoring the intrinsic (tryptophan) fluorescence during Ca2+ or Mg2+ titration in 0.15 M KCl, 2 mM Tris, pH 7.3. Fluorescence spectra were obtained using a PerkinElmer Life Sciences Luminescence Spectrometer LS 50 B connected to a Julabo F25 water bath at 25.0 °C. Quartz cuvettes with a path length of 10 mm were used. The excitation wavelength was 280 nm, and the emission scanned was between 300 and 450 nm. The protein concentration was 25 µM. Ca2+-free protein was titrated with increasing amounts of metal ion (Ca2+ or Mg2+) beyond saturation. The intensity at each point was corrected for dilution. Ca2+ and Mg2+ titrations were also performed in the presence of 120 µM ANS (excitation at 385 nm, emission scanned between 400 and 600 nm) with 10 µM calbindin D28k in 10 mM DTT, 0.15 M KCl, 2 mM Tris, pH 7.1. In some experiments, MgCl2 was added to a final concentration of 1 or 5 mM. The excitation wavelength was 385 nm (bandwidth 3 nm), and the emission was scanned between 400 and 600 nm. The experimental data were fitted according to Equation 5,


I=I<SUB>0</SUB>+(I<SUB>p</SUB>−I<SUB>0</SUB>)<FR><NU>Y · K<SUB>A</SUB></NU><DE>1+Y · K<SUB>A</SUB></DE></FR> (Eq. 5)
where Y is the free Ca2+ or Mg2+ concentration; KA is the apparent binding constant, and I0 and Ip are the intensities for the free and bound state, respectively.

Limited Proteolysis of Calbindin D28k-- Calbindin D28k was dissolved in 50 mM Tris, 150 mM KCl, containing either 1 mM CaCl2, 1 mM EDTA, or 2.5 mM MgCl2 + 0.5 mM EGTA (EGTA has a very high selectivity for Ca2+ over Mg2+) at a protein concentration of 0.5 mg/ml. The pH was adjusted to 7.5. Sequencing grade modified trypsin (Promega) was dissolved in the supplied buffer, yielding a stock solution with a concentration of 0.5 mg/ml. Proteolysis was initiated by mixing 100 µl of calbindin D28k (0.5 mg/ml) with 1 µl of the trypsin stock at room temperature. Aliquots of 5 µl were withdrawn at various time points, and the digestion was blocked by the addition of 1 µl of soybean trypsin inhibitor (1 mg/ml) (Roche Molecular Biochemicals). The digested fragments were then separated by SDS-PAGE (15%). Following electrophoresis, the protein bands were either stained by Coomassie Blue and excised for mass spectrometry analysis (see below) or blotted onto a poly(vinylidene difluoride) membrane (Immobilon, Millipore) and subjected to N-terminal amino acid sequencing (automated Edman degradation using an Applied Biosystems 477 A sequencer with on-line detection of phenylthiohydantoin-derivatives with an Applied Biosystems 120A high pressure liquid chromatography).

Sample Preparation for Mass Spectrometry-- Coomassie-stained protein fragments were excised from the gel and washed with water, followed by 40% acetonitrile in 25 mM NH4HCO3, pH 7.8, until the gel piece was transparent. The gel piece was dried in a SpeedVac vacuum centrifuge. Reduction using 10 mM DTT at 48 °C for 30 min was followed by alkylation in 55 mM iodoacetamide for 30 min in darkness at room temperature. The gel piece was washed and dried again before digestion with sequencing-grade trypsin (Promega) in 25 mM NH4HCO3 overnight at 37 °C. The digestion was terminated, and the peptides were eluted by adding 10 µl of 2% trifluoroacetic acid. Peptides were purified from buffer using C-18 reversed phase tips (Ziptips, Millipore).

Mass Spectrometry-- Mass spectrometric studies were performed using a Bruker Scout 384 Reflex III matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometer. The instrument was operated in the positive ion mode with delayed extraction and an acceleration voltage of 25 kV. Peptide samples were analyzed using the reflector detector with 2,5-dihydroxybenzoic acid as matrix, whereas larger fragments and intact protein were measured in the linear mode using ferulic acid as matrix. Improved signal-to-noise ratios were obtained by the accumulation of 50-150 single shot spectra. Autolysis fragments of trypsin were used for internal calibration, whereas an external calibration standard was used for the analysis of intact protein fragments.

NMR Spectroscopy-- NMR spectra were acquired on a 600-MHz Varian Inova spectrometer at 310 K. 15N HSQC experiments utilizing pulsed field gradient and preservation of equivalent path (32, 33) employing water flip-back (34) were performed on calbindin D28K at different Mg2+ or Ca2+ concentrations. The GARP-1 decoupling sequence (35) was used for 15N decoupling during acquisition. All spectra were acquired with spectral widths of 2000 and 8000 Hz in the F1 and F2 dimensions, respectively, and sampled using 128 and 1024 complex points in the t1 and t2 dimensions, respectively, with 16 transients acquired for each free induction decay. The data were processed and analyzed using the Felix97 Software (Micron Separations, San Diego). The data were multiplied by exponential (F2) and cosine-bell (F1) functions prior to Fourier transformation, and zero-filled to generate matrices of 2048 × 2048 real points. Proton chemical shifts were referenced relative to the water signal, which resonates at 4.64 ppm from the sodium 2,2-dimethyl-2-silapentane sulfonate (DSS) at 310 K. Nitrogen chemical shifts were referenced indirectly relative to DSS, using the nitrogen to proton frequency ratio (36).

The NMR samples contained 0.73 mM apocalbindin D28k (with less than 0.05 eq of Ca2+), 0.1 mM DSS, 10 mM deuterated DTT and were prepared by dissolving the lyophilized protein and deuterated DTT in 620 µl of 93% 1H2O, 7% 2H2O. The pH was adjusted to 6.8 with 0.1 M KOH or HCl. Aliquots from a 73 mM CaCl2 stock solution was added to one sample directly in the NMR tube using a Hamilton syringe (5 µl for each point of the titration). The protein concentration was determined by amino acid analysis following acid hydrolysis. The concentration of the CaCl2 stock solution was determined by inductively coupled plasma mass spectrometry. HSQC spectra were also acquired for a 0.8 mM protein sample with 2 or 10 mM MgCl2 as well as with 10 mM MgCl2 and 5 mM CaCl2.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Ca2+ Binding Determined from Competition with Chromophoric Chelators-- Titration with Ca2+ in the presence of a chromophoric chelator was used to determine the macroscopic Ca2+ binding constants (30, 37). To minimize experimental errors, care was taken to determine accurately the Ca2+ concentrations before and after titration (by high resolution inductively coupled plasma mass spectrometry), as well as the protein concentration before titration (by amino acid analysis after acid hydrolysis). Reliable acid hydrolysis results were obtained only when an aliquot of the sample was freeze-dried in the hydrolysis tube (glass) before shipment to the analysis station. Samples sent as liquid in Eppendorf tubes yielded unreasonably low and inconsistent protein concentrations, probably due to protein adhesion to the plastic.

The stoichiometry of Ca2+ binding was analyzed by fitting each titration in a simplified way using Equations 1-3 with n = 2. CP0 was set to the value obtained by acid hydrolysis, and the parameter F was used as a variable parameter. After fitting, the stoichiometry was calculated as 2F. By using this method, the number of high affinity Ca2+-binding sites in the intact protein are 4.03 ± 0.11 (average and S.D. of 9 titrations). Thus the data convincingly show that human calbindin D28k binds 4 Ca2+ ions with high affinity.

To obtain the values of the four macroscopic binding constants, each titration was then fitted using Equations 1-3 with n = 4. CP0 was set to the value obtained by acid hydrolysis, and F was fixed at 1.0. The intact protein displayed macroscopic binding constants of 1.5·107 to 3.5·108 M-1 at low ionic strength and 8.9·105 to 7.9·106 M-1 in 0.15 M KCl (Table I).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Macroscopic Ca2+ binding constants for calbindin D28k

The Ca2+ titration curves display a close to linear decrease of the absorbance as a function of total Ca2+ concentration. The lack of sigmoidal shape may indicate a low degree of cooperativity of Ca2+ binding. More quantitative information on the cooperativity is derived from the relationships between the macroscopic binding constants. For a protein with four Ca2+-binding sites, values of lgK1 - lgK2 < 0.426, lgK2 - lgK3 < 0.352, lgK3 - lgK4 < 0.426, and lgK1 - lgK 4 < 1.204 imply positive cooperativity (38). The results obtained here for the intact protein in the absence of Mg2+ yield the following: lgK1 - lgK2 = 0.393; lgK2 - lgK3 = 0.275; lgK3 - lgK4 = 0.281; and lgK1 - lgK4 = 0.948. Hence there is only a low degree of cooperativity of Ca2+ binding. In the presence of 2 mM Mg2+, however, the values obtained are as follows: lgK1 - lgK2 = 0.18; lgK2 - lgK3 = 0.55; lgK3 - lgK4 = 0.03; and lgK1 - lgK4 = 0.80. This indicates that the cooperativity of Ca2+ binding is greater in the presence of Mg2+, which is the relevant physiological condition. In summary, our results clearly show that calbindin D28k has four high affinity Ca2+-binding sites, which act as a cooperative unit. Hence the situation is very different from calmodulin, in which the four sites are distributed into two groups with different affinity (30).

Ca2+ Binding Monitored by Trp Fluorescence-- Calbindin D28k contains two Trp residues located in the first helix of EF-hands 1 and 3, respectively. Analysis of the Ca2+ titration curve monitored by Trp fluorescence for calbindin D28k yields an apparent binding constant of around 1·106 M-1 in 0.15 M KCl, which is similar to that obtained by Ca2+ titrations with chromophoric chelators. Although the titration monitored by Trp fluorescence does not provide the high precision obtained using the competitive chromophoric chelator method, it does confirm that the binding constants obtained by the chelator method are in the correct range.

Ca2+ Binding as Monitored by NMR Spectroscopy-- Ca2+ binding to calbindin D28k was monitored by heteronuclear two-dimensional 15N-1H HSQC NMR spectroscopy for samples containing 0-6 eq of Ca2+. In the absence of Ca2+, the signals are broad, and there are few well resolved resonances (Fig. 2A). Addition of Ca2+ to the protein sample causes significant changes in the HSQC spectrum. The HSQC spectrum of the Ca2+-saturated form shows predominantly sharp resonances and improved spectral resolution (Fig. 2D). In the absence of Ca2+, no aggregation or dimerization of the protein is observed by size exclusion chromatography when 100 µl of a 1 mM protein sample is injected on a Superdex 75 column (1.1 × 30 cm; Amersham Biosciences, data not shown). Therefore, the NMR signals of the apo state are probably broadened due to exchange between at least two conformational states with a fast-to-intermediate rate on the NMR chemical shift time scale. During the titration, the cross-peaks initially remain broadened (Fig. 2, B and C) but start to become sharper after the addition of 3 eq of Ca2+. Between 3 and 4 eq, very large changes in the spectrum are seen, both in terms of line widths and chemical shift dispersion. No further changes are observed beyond 4 eq of Ca2+.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 2.   Two-dimensional 1H-15N HSQC spectra of uniformly 15N-labeled calbindin D28k recorded at 310 K and at Ca2+/calbindin D28k ratios of 0 (A), 2.4 (B), 3.2 (C), and 4.0 (D).

The NMR signals of the apo form disappear, and new ones appear during the Ca2+ titration. This shows that Ca2+ dissociation from calbindin D28k occurs in the slow exchange regime of the NMR chemical shift time scale. The Ca2+ binding process was therefore followed by measuring the intensity of individual cross-peaks, well resolved in the HSQC spectrum as a function of Ca2+ concentration. The signals are grouped according to their behavior between 0 and 4 eq of Ca2+ in Fig. 3, A-C. A small number of resonances are affected already by the addition of the 1st eq of Ca2+; others start to increase during the addition of the 2nd or the 3rd eq of Ca2+. However, the majority of the signals do not appear until addition of the 3rd or 4th eq.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   Signal intensities of cross-peaks in the two-dimensional 1H-15N HSQC spectra of calbindin D28k as a function of the Ca2+/calbindin D28k ratio. A-C, normalized experimental data grouped according to the shape of the curve. D, fraction of the protein in the apo, Ca1, Ca2, Ca3, and Ca4 forms during the titration calculated using the four macroscopic binding constants.

Ca2+ binding to a four-site system may be a multibranched process involving one apo state, four Ca1 states, six Ca2 states, four Ca3 states, and one Ca4 state. Using the macroscopic calcium binding constants, determined by the chelator method, we have calculated for each point of the HSQC Ca2+ titration the fraction of the protein in (i) the apo, (ii) any of the Ca1 states, (iii) any Ca2 state, (iv) any Ca3 state, and (v) the Ca4 state (Fig. 3D). Comparisons of the calculated curves with the NMR data reveal that a majority of the NMR titration curves monitor the appearance of the Ca4 state. This shows that most protons have a unique chemical shift in the Ca4 form. A minority of titration curves follow the disappearance of the apo state, whereas none of the monitored peaks seems to correspond to curves expected for any of the Ca1, Ca2 or Ca3 forms. This suggests that the intermediate states are interconverting rapidly, leading to severe broadening of the resonances. The small number of resonances appearing before addition of the 3rd eq of Ca2+ may represent protons having the same chemical shift in one or more intermediate states as in the Ca4 species. The NMR data hence show that all four sites have similar affinities and are filled in a parallel fashion and that the Ca4 species has structural features distinct from those of the intermediate states.

Mg2+ Binding as Monitored by Trp Fluorescence-- Titration with MgCl2 to saturation results in a 10% increase of the fluorescence intensity at 333 nm and gives a small but reproducible blue shift of the intensity maximum from 333.5 to 332.5 nm (not shown). Addition of excess Ca2+ to the Mg2+-saturated sample results in an additional 15% increase in the fluorescence intensity (not shown). This shows that, although Mg2+ binds to the protein, it does not invoke the same structural response as Ca2+ binding. The Mg2+ titration curve in the absence of Ca2+ yields an apparent Mg2+ binding constant of 1.4 × 103 M-1 in 0.15 M KCl (average of four independent experiments). The stoichiometry of Mg2+ binding cannot be deduced from the experiment, because the Mg2+ concentration at half-saturation is almost 2 orders of magnitude higher than the protein concentration. However, the obtained binding constant implies that under physiological intracellular concentrations of Mg2+ (0.5-2 mM) and resting levels of Ca2+, the Mg2+-binding sites in calbindin D28k are 40-75% occupied by Mg2+.

Mg2+ Binding as Monitored by NMR Spectroscopy-- Mg2+ binding to calbindin D28k was also monitored by heteronuclear two-dimensional 15N-1H HSQC NMR experiments. Fig. 4 shows spectra recorded using 0.8 mM Ca2+-free protein samples containing 2 and 10 mM Mg2+, corresponding to 2.5 and 12.5 eq of Mg2+, respectively. Addition of Mg2+ to the apoprotein causes an increase in the chemical shift dispersion with a number of shifted peaks, although the effects are not as pronounced as during addition of Ca2+. Even at 10 mM Mg2+, most of the peaks are still broadened and clustered between 8.5 and 7 ppm in the proton dimension and between 121 and 115 ppm in the nitrogen dimension. Addition of 3.2 mM Ca2+ (4 eq) to the sample with 10 mM Mg2+ yields an HSQC spectrum that is identical to the one in Fig. 2D (data not shown). This shows that Ca2+ efficiently displaces Mg2+, suggesting that Mg2+ binds to the same sites as Ca2+.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 4.   Two-dimensional 1H-15N HSQC spectra of uniformly 15N-labeled calbindin D28k recorded at 310 K with 0.8 mM Ca2+-free protein samples containing 2 and 10 mM Mg2+ (corresponding to 2.5 and 12.5 eq of Mg2+, respectively).

Mg2+ Binding to Individual EF-hands as Monitored by CD Spectroscopy-- The far-UV CD spectra were recorded for six synthetic peptides, comprising EF-hands 1-6, at a concentration of 20 µM. The six peptides appear mostly unfolded in the apo form as well as in the presence of 10 or 200 mM MgCl2 (data not shown). This is in striking contrast to the spectra obtained in the presence of Ca2+, which show a high degree of helicity and are consistent with Ca2+ binding for EF1, EF3, EF4, EF5, and EF6 (39). The results suggest that although Mg2+ binds to the intact protein, the interaction between Mg2+ and the individual EF-hands is not strong enough to induce secondary structure in these peptides.

Ca2+ Binding in the Presence of Mg2+ and a Chromophoric Chelator-- Ca2+ binding in the presence of Mg2+ was determined using a chromophoric Ca2+ chelator (5,5'Br2-BAPTA), which has a high level of discrimination against Mg2+. Fig. 5 shows the experimental data for Ca2+ titrations of intact calbindin D28k in the presence of 0 or 2 mM Mg2+, together with the curves of best fit. Already from the appearance of the curves it is evident that the presence of Mg2+ reduces the Ca2+ affinity for calbindin D28k. The fitting of the experimental data shows that the Ca2+ affinity of calbindin D28k is reduced approximately 2-fold to yield K = 3.5·106-5.6·105 M-1 in the presence of 2 mM MgCl2 (Table I). Only very small ionic strength effects are expected for the addition of 2 mM MgCl2 into 0.15 M KCl. Therefore, the data again suggest that Mg2+ competes with Ca2+ for the same binding sites.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 5.   Titration of 5,5'Br2-BAPTA with Ca2+ in the presence of calbindin D28k with or without Mg2+ in 0.15 M KCl, 2 mM Tris, pH 7.3. The curves of optimal fit to the data points are presented. open circle , titration performed without MgCl2. , titration performed in the presence of 2 mM MgCl2.

Changes in the Tertiary Structure as Monitored by Near UV-CD-- Ca2+ binding induces changes in the near-UV CD spectra of calbindin D28k, which indicates a rearrangement of the tertiary structure (not shown, see also Ref. 28), in agreement with the NMR data. In contrast, addition of 10 mM MgCl2 to apocalbindin D28k does not alter the near-UV CD spectrum to any significant degree (not shown).

Limited Proteolysis-- Limited tryptic digestion of human recombinant calbindin D28k was performed in the presence of EDTA, Ca2+, or Mg2+. The reaction was quenched at different time points ranging from 1 min to 14 h and was analyzed by SDS-gel electrophoresis (Fig. 6). Both the rate and pattern of tryptic digestion are strongly Ca2+-dependent. The Ca2+-loaded form of calbindin D28k is clearly more resistant to proteolysis than the Ca2+-free form, although many of the potential trypsin cleavage sites are protected in both forms (Fig. 1). Significant digestion of the apo form is seen already in the 1st min, whereas fragments of the Ca2+-loaded form appear at a significantly lower rate. The identities of the tryptic fragments were determined by mass spectrometry and N-terminal amino acid sequencing. The deduced cleavage sites are indicated by the arrows in Fig. 7, and the identity of the major fragments are summarized in Table II. Both apo- and Ca2+-bound calbindin are cleaved at Lys-59 and Lys-235 in the N-terminal helices of EF-hands 2 and 6. The apoprotein is cleaved also at Arg-169 in the C-terminal helix of EF-hand 4. In contrast, the Ca2+-bound protein is not cleaved at this site but mainly at Lys-72 in the loop of EF-hand 2 and at Lys-98 in the linker between EF-hands 2 and 3. In addition, a minor cleavage site in the Ca2+ form is found at Lys-245 in the loop of EF-hand 6. 


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 6.   Tryptic digestion of calbindin D28k. Human recombinant calbindin D28k was digested with trypsin as described under "Experimental Procedures." Fragments were generated in the presence of 1 mM CaCl2, in the presence of 1 mM EDTA, or in the presence of or 2.5 mM MgCl2 + 0.5 mM EGTA and separated by SDS-PAGE (15%), transferred to an Immobilon membrane, and stained with Coomassie Brilliant Blue.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 7.   Limited proteolysis of calbindin D28k. Schematic of calbindin D28k outlining secondary structure elements, including the helix-loop-helix motifs and major tryptic fragments generated in 1 mM CaCl2 (A) and 1 mM EDTA (B). EF-hand motifs 1-6 are shown by arabic numbers. EF hands 2 and 6, which contain sequence anomalies, are shown by dashed lines. The major cleavage sites are indicated by arrows. The regions that display a difference in the cleavage patterns between the Ca2+ and apo forms are shaded boxes.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Analysis of tryptic peptides of calbindin D28k by Edman degradation and mass spectrometry
Human calbindin D28k was digested with trypsin; fragments were separated by SDS-PAGE (15%), and gels were stained with Coomassie Blue. Samples were collected after various time points. In some experiments, the bands were blotted onto an Immobilon membrane.

At longer incubation times, a number of small fragments appear. These are mainly due to further cleavage of larger fragments and may therefore represent cleavage sites that are inaccessible in the intact protein. It is noteworthy that in EDTA a small fragment containing residues 181-261 (EF-hands 5 and 6) is fairly resistant to further cleavage as its intensity increases all the way up to the last time point (120 min, band A8 in Fig. 6).

Limited proteolysis of calbindin D28k in the presence of 2 mM Mg2+ results in nearly the same digestion pattern as for the apoprotein (Fig. 6). Thus, all identified fragments were equivalent in the EDTA and Mg2+ samples, except for a very small amount of a peptide (residues 60-261),2 which was not found in the EDTA samples. Mg2+ seems to offer some protection to proteolytic digestion, although digestion is much faster than in the presence of Ca2+.

Ca2+ Binding to F123 and F456 as Monitored by the Chromophoric Chelator Quin 2-- Ca2+ binding to F123 and F456, each comprising one-half of calbindin D28k, was measured with the quin 2 method. The stoichiometry of Ca2+ binding to each half was analyzed as described for the intact protein, yielding n = 2.01 ± 0.22 for F123 and 2.14 ± 0.24 for F456. Hence, there are two high affinity sites in each half of calbindin D28k. One site in each half was found to retain the Ca2+ affinity of the intact protein (K1 approx 1 × 108 M-1). The second site in each half binds Ca2+ with ~50-fold lower affinity (K2 approx 2 × 106 M-1).

Ca2+-induced Conformational Changes as Monitored by ANS Fluorescence-- The fluorescent probe ANS can be used as a sensitive reporter of solvent-exposed hydrophobic patches in proteins. In an attempt to investigate whether F123 and F456 undergo Ca2+-induced conformational changes at the tertiary level, we measured the Ca2+ dependence of ANS binding for F123 and F456. In EDTA, both F123 (472 nm) and F456 (485 nm) yield a significant blue shift and intensity increase relative to ANS in buffer (530 nm), indicating binding of ANS. When Ca2+ is added, a further blue shift in the fluorescence maximum from 485 to 475 nm is observed for F456 with a 30% increase in intensity (Fig. 8B). In contrast, addition of Ca2+ to F123 yields a 43% decrease in intensity, with a shift from 472 to 483 nm. The results clearly indicate that both halves undergo structural changes after binding of Ca2+. The response is different in the two halves with the local environment around the bound ANS becoming less polar in F456 but more polar in F123.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 8.   ANS binding to F123 and F456. F123 () or F456 (open circle ) was dissolved to 6 µM each in 2 ml of 60 µM ANS, 50 µM EDTA, 1 mM DTT, 0.15 M KCl, pH 7.1. The ANS fluorescence emission spectra (excitation at 385 nm) were first recorded at room temperature for the Ca2+-free form (dotted line). CaCl2 (1 µl 1 M) was then added to each solution (solid line), and the measurements were repeated. The dash-dotted line shows the spectrum for 60 µM ANS in buffer without protein.

ANS fluorescence spectra were also recorded for an equimolar mixture of F123 and F456 and for the intact protein. These spectra were compared with one another and to the sum of the ANS spectra recorded individually for F123 and F456. No spectral differences were observed between these three cases, neither in the absence nor in the presence of Ca2+. The data suggest that ANS binds to the same exposed hydrophobic patches in the intact protein as in the two halves. Earlier work (4) has shown that each half-fragment has a tendency to form homodimers, hence the contact surface between the two halves in the intact protein would be hidden in the separate fragments and not accessible to ANS binding.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The results of the present work clearly demonstrate that the tertiary structure of calbindin D28k is Ca2+-dependent. The large Ca2+-induced effects observed by two-dimensional (1H-15N) HSQC NMR spectroscopy (Fig. 2) indicate that the protein undergoes a conformational change. Whereas the spectrum of the apo form shows limited chemical shift dispersion and broad lines, the Ca2+-saturated protein displays shift dispersion and narrow lines typical of a well folded helical protein. Far-UV CD data (28) indicate a significant degree of helicity both for the apo and Ca2+-loaded states, suggesting that the limited chemical shift dispersion of the apo form represents a loosely organized tertiary structure, similar to a molten globule. As seen in Figs. 2 and 3, there is not a progressive change in the spectrum throughout the Ca2+ titration. Rather, fairly small spectral changes are observed until 4 eq of Ca2+ are added, at which point there is a dramatic change with a large number of sharp resonances appearing. For example, four signals appear in a region where the glycine residue in position 6 of the Ca2+-bound EF-hand loop is typically found (delta 1H = 10-10.5 ppm, delta 15N = 110-114 ppm). These signals most likely represent the corresponding four glycine residues of the regular EF-hands 1 and 3-5, because synthetic peptides corresponding to these four sites also display 1H chemical shifts of these glycine residues between 10 and 10.5 ppm in the Ca2+-bound form (39). Whereas data on the rat protein have been interpreted as one site having much higher affinity than two or three other sites (40), we do not observe sites differing in affinity. Rather, we have strong evidence from the quin 2 and NMR titrations that all four sites bind Ca2+ in a parallel fashion with similar affinity and positive cooperativity.

Limited tryptic proteolysis of the apo- and Ca2+ proteins (Figs. 6 and 7 and Table II) provides further details on the Ca2+-induced structural changes. In accordance with the HSQC results, the protein appears more loosely folded in the apo state, because it is considerably more sensitive to proteolysis than in the Ca2+-loaded state. The cleavage patterns are also distinctly different. Whereas the apoprotein is mainly cleaved at Arg-169, the Ca2+ form is cleaved at Lys-72 and Lys-98. Arg-169 is located in the middle of the second helix of EF-hand 4, whereas Lys-72 and Lys-98 are found in the loop of EF-hand 2 and in the N-terminal helix of EF hand 3, respectively. This suggests that the conformational changes upon Ca2+ binding involve burial or rotation of the second helix in EF-hand 4 and exposure of the loop of EF-hand 2 and of the N-terminal helix of EF hand 3. EF-hand 2 is a variant site that does not appear to bind Ca2+ (39), and its Ca2+-induced exposure to solvent is intriguing. One could speculate that EF-hand 2 is part of a target-binding surface that becomes exposed upon Ca2+ binding.

It is interesting to compare the limited proteolysis of calbindin D28k to the digestion patterns of calretinin. Calretinin is a hexa-EF-hand protein that is homologous to calbindin D28k (58% sequence identity), but in contrast to calbindin, it binds Ca2+ to EF-hand 2. In calretinin, regions in EF-hands 2 and 3 are not cleaved in the presence of Ca2+, which indicates that this part of the protein is not exposed to solvent in a Ca2+-dependent way (41, 42). Instead, cleavage occurs in EF-hand 6 of calretinin, which corresponds to a minor Ca2+-induced cleavage point in calbindin D28k. EF-hand 6 represents a non-canonical sequence in both proteins. The dissimilarities in digestion pattern may reflect functional and evolutionary differences between the two proteins to adapt to different targets.

The heteronuclear two-dimensional 15N-1H HSQC NMR experiments show that Ca2+ efficiently displaces Mg2+, suggesting that Mg2+ binds to the same sites as Ca2+. The results from limited proteolysis, near-UV CD, and NMR spectroscopy show that the structural changes upon Mg2+ binding are much smaller than upon Ca2+ binding. This indicates that although Mg2+ binds to calbindin D28k, it coordinates in such a way that is does not drive any substantial conformational change. This is consistent with structural data on other EF-hand proteins, which show that the coordination of Mg2+ and Ca2+ to the same site generally differs (43). The bidendate Ca2+-ligating glutamate at position 12 in the EF-hand loop is important for inducing conformational changes in Ca2+ sensor proteins. In the Mg2+-loaded form, the ion is often coordinated by none or only by one of the side chain oxygens of this glutamate side chain.

Each of the two isolated halves, comprising EF-hands 1-3 and 4-6, respectively, was found to contain two high affinity Ca2+-binding sites. In each of the two halves, one site retains the Ca2+ affinity as seen for intact calbindin D28k, whereas the other site has lost affinity by a factor of 50. Hence, truncation of the protein leads to loss of important interactions between EF-hands at the interface between the two halves. Thus, the Ca2+-binding sites of calbindin D28k are clearly not grouped into two largely independent domains, as in calmodulin. The two halves of calmodulin retain native-like Ca2+ binding behavior even when separated (44). The present Ca2+ binding data, obtained for F123 and F456, support earlier findings that all six EF-hands in calbindin D28k are part of one globular domain (3, 4).

Calbindin D28k appears to have evolved through triplication of an ancestral gene coding for two EF-hands (5). EF-hands often associate in pairs as they occur in the sequence, but in calbindin D28k there are also extensive interactions beyond the pairwise contacts (3, 4). As isolated synthetic peptides, EF-hands 1 and 3-5 in calbindin D28k are the main Ca2+-binding sites, whereas EF-hand 2 fails to bind Ca2+ and EF-hand 6 does so only weakly (39). Hence, it seems reasonable to assume that EF-hands 1 and 3 are active in the Ca2+ titrations of the N-terminal half and EF-hands 4 and 5 of the C-terminal half. An attractive model for the intact protein is that EF hands 3 and 4 are paired with one another. A cut in this pair would then have major influences on the Ca2+ affinity for both EF-hands 3 and 4, which could explain the reduced Ca2+ affinity of one site in each half. In this model, the conformational properties and high Ca2+ affinities of EF-hands 1 and 5 depend mostly on interactions within the respective half.

The physiological role of calbindin D28k as a neuroprotector in conditions related to Ca2+ overload, and as a facilitator of neuronal Ca2+ signaling and renal Ca2+ resorption, has been suggested to be linked to the Ca2+-buffering capacity of the protein. However, Ca2+-induced conformational changes, reported in an earlier study (28) and further analyzed in the present work, suggest that some of the physiological findings could be due to Ca2+ sensor activity of calbindin D28k. All cells have transport systems for the extrusion of Ca2+. The intracellular Ca2+ concentration in a resting cell is therefore relatively low, <0.1 µM. The cytosolic Ca2+ concentration can be abruptly raised to 1-10 µM when the cell is activated by influx of Ca2+. In the activated cell, Ca2+ is bound in a highly selective way to Ca2+-signaling proteins (Ca2+ sensors) and induce conformational changes, which lead to an altered activity of target proteins. As discussed above, calbindin D28k clearly undergoes a Ca2+-induced conformational change; however, to be classified as a Ca2+ sensor, several other conditions also need to be fulfilled. The intracellular concentration of Mg2+, a potential competitor to Ca2+, is kept at a relatively constant level around 0.5-2 mM. Consequently, a Ca2+ sensor protein must have ~1000-fold selectivity for Ca2+ over Mg2+. This condition is met by calbindin D28k as the protein binds to Mg2+ with an affinity constant around 1.4·103 M-1 in 0.15 M KCl, where the average Ca2+ binding constant is 2.5·106 M-1. A Ca2+ sensor must further be able to respond structurally within a biologically relevant range of intracellular Ca2+ concentrations. This is also true for calbindin as its average Ca2+ dissociation constant (Kd,av = 7·10-7 M) falls within the physiological range of intracellular free Ca2+ concentrations. In contrast, a Ca2+-buffer protein would be expected to have higher affinity (Kd <10-7 M), whereas Ca2+-binding proteins with a lower affinity (Kd >10-5 M) cannot act as sensors because they are unable to detect the changes in intracellular free Ca2+ concentrations that normally occur in cells. Fig. 9 shows the Ca2+ saturation curves for calbindin D28k, calmodulin, and parvalbumin calculated from the Ca2+ binding constants in 0.15 M KCl and 1-2 mM MgCl2. Parvalbumin is considered to be a Ca2+-buffering protein and binds Ca2+ with ~20 times higher affinity than calbindin D28k. It is clear from Fig. 9 that parvalbumin cannot be a Ca2+ sensor because it is almost fully saturated with Ca2+ at resting concentrations of Ca2+. By contrast, calbindin D28k and calmodulin are only <= 9 and <= 3% saturated with Ca2+, respectively, at resting concentrations of Ca2+ (<= 0.1 µM). At Ca2+ concentrations similar to those that follow Ca2+ activation of a cell, the saturation levels of calbindin D28k and calmodulin are changed dramatically, as would be expected for Ca2+ sensors.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 9.   Ca2+ saturation curves for parvalbumin, calmodulin, and calbindin D28k. The degree of saturation as a function of free Ca2+ concentration was calculated from the macroscopic binding constants in 1-2 mM Mg2+ and 0.15 M KCl, pH 7.3. The Ca2+ concentration intervals of a resting and activated cell are shaded.

If calbindin D28k is a Ca2+ sensor, by which mechanism could it work? As mentioned above, the Ca2+-binding sites of calbindin D28k are clearly not grouped into two largely independent domains, as seen in calmodulin. Therefore, it does not follow the calmodulin paradigm of having two independent domains, which expose hydrophobic surfaces only upon Ca2+ binding, and that together clamp around the recognition sequences of target enzymes (45). Instead, the tryptic digestion patterns suggest that the Ca2+-induced conformational changes involve the rotation of helices and the reorganization of the interface between EF-hands and the linker loops. The mechanism may resemble the Ca2+-induced changes observed for recoverin (46), a protein with 4 EF-hands organized in a single globular domain. Alternatively, calbindin D28k may function by a unique mechanism, possibly shared with other hexa-EF-hand proteins.

    FOOTNOTES

* This work was supported by Swedish Natural Science Research Foundation Grants NFR K-Ku.10178 (to S. L.) and NFR 104739 (to M. A.), Inga-Britt och Arne Lundbergs Research Foundation grant (to P. Ö.), a National Science Foundation Career grant (to K. S. Å.), and a postdoctoral fellowship from FEBS (to S. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence may be addressed. Tel.: 46-46-2228246; Fax: 46-46-2224543; E-mail: tord.berggard@bpc.lu.se.

Dagger Dagger To whom correspondence may be addressed. Tel.: 46-46-2228246; Fax: 46-46-2224543; E-mail: Sara.Linse@bpc.lu.se.

Published, JBC Papers in Press, February 28, 2002, DOI 10.1074/jbc.M200415200

2 Fragments A3 and Mg3 also start at residue 60. The molecular weight as estimated from SDS-PAGE (25-26 kDa) of fragments A3 and Mg3 is higher than the maximum possible weight of a polypeptide starting at residue 60. It is possible that A3 and Mg3 contain more than one fragment that together form a complex strong enough to resist separation during the conditions of the gel electrophoresis.

    ABBREVIATIONS

The abbreviations used are: BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; HSQC, heteronuclear single quantum coherence; ANS, 8-anilinonaphthalene-1-sulfonic acid ammonium salt; DTT, 4-dithiothreitol; DSS, 2,2-dimethyl-2-silapentane sulfonate; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Christakos, S., Gabrielides, C., and Rhoten, W. B. (1989) Endocr. Rev. 10, 3-26[CrossRef][Medline] [Order article via Infotrieve]
2. Oberholtzer, J. C., Buettger, C., Summers, M. C., and Matschinsky, F. M. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 3387-3390[Abstract/Free Full Text]
3. Linse, S., Thulin, E., Gifford, L. K., Radzewsky, D., Hagan, J., Wilk, R. R., and Akerfeldt, K. S. (1997) Protein Sci. 6, 2385-2396[Abstract]
4. Berggård, T., Thulin, E., Akerfeldt, K. S., and Linse, S. (2000) Protein Sci. 9, 2094-2108[Abstract]
5. Kawasaki, H., Nakayama, S., and Kretsinger, R. H. (1998) Biometals 11, 277-295[CrossRef][Medline] [Order article via Infotrieve]
6. Yap, K. L., Ames, J. B., Swindells, M. B., and Ikura, M. (1999) Proteins 37, 499-507[CrossRef][Medline] [Order article via Infotrieve]
7. Zhang, M., and Yuan, T. (1998) Biochem. Cell. Biol. 76, 313-323[CrossRef][Medline] [Order article via Infotrieve]
8. Pauls, T. L., Cox, J. A., and Berchtold, M. W. (1996) Biochim. Biophys. Acta 1306, 39-54[Medline] [Order article via Infotrieve]
9. Chard, P. S., Bleakman, D., Christakos, S., Fullmer, C. S., and Miller, R. J. (1993) J. Physiol. (Lond.) 472, 341-357[Abstract/Free Full Text]
10. Airaksinen, M. S., Eilers, J., Garaschuk, O., Thoenen, H., Konnerth, A., and Meyer, M. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1488-1493[Abstract/Free Full Text]
11. Chard, P. S., Jordan, J., Marcuccilli, C. J., Miller, R. J., Leiden, J. M., Roos, R. P., and Ghadge, G. D. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5144-5148[Abstract/Free Full Text]
12. Mattson, M. P., Rychlik, B., Chu, C., and Christakos, S. (1991) Neuron 6, 41-51[CrossRef][Medline] [Order article via Infotrieve]
13. Li, Z., Decavel, C., and Hatton, G. I. (1995) J. Physiol. (Lond.) 488, 601-608[Medline] [Order article via Infotrieve]
14. Dowd, D. R., MacDonald, P. N., Komm, B. S., Haussler, M. R., and Miesfeld, R. L. (1992) Mol. Endocrinol. 6, 1843-1848[Abstract]
15. Guo, Q., Christakos, S., Robinson, N., and Mattson, M. P. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 3227-3232[Abstract/Free Full Text]
16. Lukas, W., and Jones, K. A. (1994) Neuroscience 61, 307-316[CrossRef][Medline] [Order article via Infotrieve]
17. Iacopino, A. M., and Christakos, S. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4078-4082[Abstract/Free Full Text]
18. Klapstein, G. J., Vietla, S., Lieberman, D. N., Gray, P. A., Airaksinen, M. S., Thoenen, H., Meyer, M., and Mody, I. (1998) Neuroscience 85, 361-373[CrossRef]